The safety of the perioperative administration of cyclooxygenase-2 inhibitors for post-surgical pain.
Reuben
S S
SS
D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000009:adverse effects / Q000627:therapeutic use; D001178:Arthroplasty / Q000379:methods; D016063:Blood Loss, Surgical / Q000517:prevention & control; D000068579:Celecoxib; D002648:Child; D016861:Cyclooxygenase Inhibitors / Q000009:adverse effects* / Q000627:therapeutic use; D006801:Humans; D007783:Lactones / Q000009:adverse effects / Q000627:therapeutic use; D010149:Postoperative Pain / Q000517:prevention & control*; D019990:Perioperative Care / Q000009:adverse effects* / Q000379:methods*; D011183:Postoperative Complications / Q000517:prevention & control; D011720:Pyrazoles / Q000009:adverse effects / Q000627:therapeutic use; D013449:Sulfonamides / Q000009:adverse effects / Q000627:therapeutic use; D013450:Sulfones / Q000009:adverse effects / Q000627:therapeutic use; D014068:Tonsillectomy / Q000379:methods; D016896:Treatment Outcome
D000894:Anti-Inflammatory Agents, Non-Steroidal; D016861:Cyclooxygenase Inhibitors; D007783:Lactones; D011720:Pyrazoles; D013449:Sulfonamides; D013450:Sulfones; C116926:rofecoxib; D000068579:Celecoxib